Literature DB >> 31381308

A Rh(III)-Catalyzed Formal [4+1] Approach to Pyrrolidines from Unactivated Terminal Alkenes and Nitrene Sources.

Sumin Lee1, Honghui Lei1, Tomislav Rovis1.   

Abstract

We have developed a formal [4+1] approach to pyrrolidines from readily available unactivated terminal alkenes as 4-carbon partners. The reaction provides a rapid construction of various pyrrolidine containing structures, especially for the diastereoselective synthesis of spiro-pyrrolidines. Mechanistic investigation suggests a Rh(III)-catalyzed intermolecular aziridination of the alkene and subsequent acid-promoted ring expansion for the pyrrolidine formation.

Entities:  

Year:  2019        PMID: 31381308     DOI: 10.1021/jacs.9b07012

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

1.  Diastereoselective Three-Component 3,4-Amino Oxygenation of 1,3-Dienes Catalyzed by a Cationic Heptamethylindenyl Rhodium(III) Complex.

Authors:  Finn Burg; Tomislav Rovis
Journal:  J Am Chem Soc       Date:  2021-10-20       Impact factor: 15.419

2.  Rh(III)-Catalyzed Three-Component Syn-Carboamination of Alkenes Using Arylboronic Acids and Dioxazolones.

Authors:  Sumin Lee; Tomislav Rovis
Journal:  ACS Catal       Date:  2021-06-30       Impact factor: 13.700

3.  Rhodium(III)-Catalyzed Three-Component 1,2-Diamination of Unactivated Terminal Alkenes.

Authors:  Sumin Lee; Young Jin Jang; Erik J T Phipps; Honghui Lei; Tomislav Rovis
Journal:  Synthesis (Stuttg)       Date:  2020       Impact factor: 3.157

Review 4.  The advent of electrophilic hydroxylamine-derived reagents for the direct preparation of unprotected amines.

Authors:  Valentina C M Gasser; Szabolcs Makai; Bill Morandi
Journal:  Chem Commun (Camb)       Date:  2022-09-08       Impact factor: 6.065

5.  A modular and divergent approach to spirocyclic pyrrolidines.

Authors:  Benjamin D A Shennan; Peter W Smith; Yusuke Ogura; Darren J Dixon
Journal:  Chem Sci       Date:  2020-08-07       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.